Table 2.
Median OS of each TNM group
| Stage (8th) | Group | Median OS (95% CI) | Stage (8th modified) | |
|---|---|---|---|---|
| SEER | Multicenter | |||
| I | T1N0M0 | 95 (73.4–116.6) | 74 (53.2–115.7) | I |
| II | T2N0M0 | 79 (56.4–101.6) | 55 (39.4–70.6) | II |
| IIIA | T3N0M0 | 20 (16.8–23.2) | 23 (13.5–34.8) | IIIA |
| IIIB | T1N1M0 | 17 (11.4–22.6) | 20 (12.6–27.1) | IIIA |
| IIIB | T2N1M0 | 24 (19.3–28.7) | 19 (12.2–28.0) | IIIA |
| IIIB | T3N1M0 | 13 (11.4–14.6) | 15 (10.1–21.7) | IIIB |
| IVA | T4N0M0 | 12 (8.1–15.9) | 12 (7.9–17.2) | IIIB |
| IVA | T4N1M0 | 10 (7.2–12.8) | 12 (7.4–16.9) | IIIB |
| IVB | T1N2M0 | 21 (0–48.4) | 22 (15.5–31.3) | IIIA |
| IVB | T2N2M0 | 20 (13.1–26.9) | 17 (10.7–26.6) | IIIA |
| IVB | T3N2M0 | 11 (9.2–12.8) | 13 (8.4–18.0) | IIIB |
| IVB | T4N2M0 | 4 (1.1–6.9) | 9 (7.1–11.9) | IV |
| IVB | TanyNanyM1 | 8 (7.2–8.8) | 7 (5.4–10.1) | IV |
OS overall survival, CI confidence interval